These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33722365)

  • 1. Evaluation of menopausal hormone therapy use in Korea (2002-2013): A nationwide cohort study.
    Park CY; Lim JY; Kim WH; Kim SY; Park HY
    Maturitas; 2021 Apr; 146():57-62. PubMed ID: 33722365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
    Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
    Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of menopausal hormonal therapy on cardiovascular risks in Korean postmenopausal women: A nationwide cohort study.
    Yuk JS; Kim GS; Byun YS; Yang SW; Kim MH; Yoon SH; Seo YS; Kim BG
    BJOG; 2024 Aug; 131(9):1306-1317. PubMed ID: 38465460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim M
    Menopause; 2023 May; 30(5):490-496. PubMed ID: 37022299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 2016.
    Heinig M; Braitmaier M; Haug U
    Pharmacoepidemiol Drug Saf; 2021 Apr; 30(4):462-471. PubMed ID: 33368726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the incidence, prevalence and sales volume of menopausal hormone therapy in Sweden from 2000 to 2021.
    Sundell M; Brynhildsen J; Spetz Holm AC; Fredrikson M; Hoffmann M
    Maturitas; 2023 Sep; 175():107787. PubMed ID: 37354643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim T; Cho H; Gwak G
    Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of menopausal hormone therapy on cardiovascular diseases and type 2 diabetes in middle-aged postmenopausal women: analysis of the Korea National Health Insurance Service Database.
    Kim JE; Choi J; Park J; Shin A; Choi NK; Choi JY
    Menopause; 2021 Sep; 28(11):1225-1232. PubMed ID: 34520413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Utilization of hormone replacement therapy in Spain: Trends in the period 2000-2014].
    Baladé Martínez L; Montero Corominas D; Macías Saint-Gerons D
    Med Clin (Barc); 2016 Oct; 147(7):287-92. PubMed ID: 27423654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea.
    Yuk JS; Seo YS; Im YH; Kim JH
    Semin Arthritis Rheum; 2023 Dec; 63():152280. PubMed ID: 37857046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.
    Huang WF; Tsai YW; Hsiao FY; Liu WC
    BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
    Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
    Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women.
    Kim H; Kang MJ; Baek JK; Lee JK; Choi EA; Yun BH; Kim EH; Seo SK
    Climacteric; 2024 Apr; 27(2):165-170. PubMed ID: 37947171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS
    Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and breast cancer incidence in Korean women.
    Choi E; Lee JK; Baek JK; Chung Y; Kim H; Yun BH; Seo SK
    Maturitas; 2024 May; 183():107946. PubMed ID: 38412593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormonal therapy in surgically menopausal women with underlying endometriosis.
    Tanmahasamut P; Rattanachaiyanont M; Techatraisak K; Indhavivadhana S; Wongwananuruk T; Chantrapanichkul P
    Climacteric; 2022 Aug; 25(4):388-394. PubMed ID: 34783284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.